HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice.

Abstract
In the present study, effects of intracerebroventricular (i.c.v.) injections of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice were investigated by using a one-trial passive avoidance task. Amnesia induced by pre-training morphine was significantly reversed in morphine-sensitized mice, which had previously received once daily injections of morphine (20 and 30 mg/kg, s.c.) for 3 days. Three daily injections of SKF 38393 (1, 2 and 4 g/mouse, i.c.v.) or SCH 23390 (0.25, 0.5, 0.75 and 1 g/mouse, i.c.v.) before morphine, and during morphine-sensitization, decreased and increased the amnesia induced by pre-training morphine respectively. Three daily injections of quinpirole (0.3, 1 and 3 g/mouse, i.c.v.) or sulpiride (0.03, 0.1, 0.3 and 1 g/mouse, i.c.v.) before morphine, also decreased and increased the amnesia induced by pre-training morphine respectively. Morphine-sensitized mice received similar injections of cholinergic agents. Three daily injections of physostigmine (1, 3 and 5 g/mouse, i.c.v.) or atropine (1, 4 and 7 g/mouse, i.c.v.) before morphine, and during morphine-sensitization, decreased and increased the amnesia induced by pre-training morphine respectively. Three daily injections of nicotine (0.75, 1 and 2 g/mouse, i.c.v.) or mecamylamine (1, 3 and 6 g/mouse, i.c.v.) before morphine, also decreased and increased the amnesia induced by pre-training morphine respectively. The results suggest that morphine sensitization affects the impairment of memory formation and thus it is postulated that central dopaminergic and cholinergic systems may play an important role in this effect.
AuthorsMohammad-Reza Zarrindast, Maryam Farahmandfar, Parvin Rostami, Ameneh Rezayof
JournalJournal of psychopharmacology (Oxford, England) (J Psychopharmacol) Vol. 20 Issue 1 Pg. 59-66 (Jan 2006) ISSN: 0269-8811 [Print] United States
PMID16174677 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Opioid
  • Cholinergic Agents
  • Dopamine Agents
  • Dopamine Agonists
  • Dopamine Antagonists
  • Muscarinic Agonists
  • Muscarinic Antagonists
  • Nicotinic Agonists
  • Nicotinic Antagonists
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Muscarinic
  • Morphine
Topics
  • Amnesia (chemically induced, psychology)
  • Analgesics, Opioid (pharmacology)
  • Animals
  • Avoidance Learning (drug effects)
  • Cholinergic Agents (administration & dosage, pharmacology)
  • Dopamine Agents (administration & dosage, pharmacology)
  • Dopamine Agonists (pharmacology)
  • Dopamine Antagonists (pharmacology)
  • Injections, Intraventricular
  • Male
  • Mice
  • Morphine (pharmacology)
  • Muscarinic Agonists (pharmacology)
  • Muscarinic Antagonists (pharmacology)
  • Nicotinic Agonists (pharmacology)
  • Nicotinic Antagonists (pharmacology)
  • Receptors, Dopamine D1 (drug effects)
  • Receptors, Dopamine D2 (drug effects)
  • Receptors, Muscarinic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: